Metabolomic profile related to cardiovascular disease in patients with type 2 diabetes mellitus: A pilot study

Talanta

Volumn 148, Issue , 2016, Pages 135-143

  García Fontana, Beatriz ^a   Morales Santana, Sonia ^a   Díaz Navarro, Caridad ^b   Rozas Moreno, Pedro ^c   Genilloud, Olga ^b   Vicente Pérez, Francisca ^b   Pérez Del Palacio, José ^b   Muñoz Torres, Mnuel ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Health Sciences Technology Park   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

Author keywords

Cardiovascular disease; Metabolomic; Phospholipids; Type 2 diabetes mellitus

Indexed keywords

BIOMARKERS; BODY FLUIDS; CARDIOLOGY; DISCRIMINANT ANALYSIS; DISEASES; LEAST SQUARES APPROXIMATIONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PHOSPHOLIPIDS;

CARDIO-VASCULAR DISEASE; GENERALIZED REDUCTION; HIGH RESOLUTION MASS SPECTROMETRY; LYSOPHOSPHATIDYL-CHOLINE; LYSOPHOSPHATIDYLETHANOLAMINE; METABOLOMICS; PARTIAL LEAST SQUARES DISCRIMINANT ANALYSES (PLSDA); TYPE 2 DIABETES MELLITUS;

ANALYSIS OF VARIANCE (ANOVA);

BLOOD; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLOMICS; MIDDLE AGED; PILOT STUDY; PROCEDURES; TANDEM MASS SPECTROMETRY;

CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; PILOT PROJECTS; TANDEM MASS SPECTROMETRY;

EID: 84945588508     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2015.10.070     Document Type: Article

References (50)

1. B.B. Lowell, and G.I. Shulman Mitochondrial Dysfunction and Type 2 Diabetes Science 307 2005 384 387 10.1126/science.1104343
2. S.M. Grundy, I.J. Benjamin, G.L. Burke, A. Chait, R.H. Eckel, B.V. Howard, and et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association Circulation. 100 1999 1134 1146 1999/09/08 ed
3. P.W.F. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 10.1161/01.CIR.97.18.1837
4. P.W. Wilson Diabetes mellitus and coronary heart disease Am. J. Kidney Dis. 32 1998 1998/11/20 ed
5. J.K. Nicholson, J. Connelly, J.C. Lindon, and E. Holmes Metabonomics: a platform for studying drug toxicity and gene function Nat. Rev. Drug. Discov. 1 2002 153 161
6. G. Theodoridis, H.G. Gika, and I.D. Wilson LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics Trac. Trends Anal. Chem. 27 2008 251 260 10.1016/j.trac.2008.01.008
7. I.-G. Chong, and C.-H. Jun Performance of some variable selection methods when multicollinearity is present Chemom. Intell. Lab. Syst. 78 2005 103 112 10.1016/j.chemolab.2004.12.011
8. M. Brown, W.B. Dunn, P. Dobson, Y. Patel, and C.L. Winder Francis-McIntyre S, et al. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics Analyst 134 2009 1322 1332 10.1039/b901179j 2009/06/30 ed
9. W.B. Dunn, D. Broadhurst, P. Begley, E. Zelena, S. Francis-McIntyre, N. Anderson. et al., Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry 6 2011 Nat Protoc, Nature Publishing Group, a division of Macmillan Publishers Limited 1060 1083.doi:http://www.nature.com/nprot/journal/v6/n7/abs/nprot.2011.335.html#supplementary-information
10. Xia J., Mandal R., Sinelnikov I.V., Broadhurst D., Wishart D.S. MetaboAnalyst 2.0 a comprehensive server for metabolomic data analysis. Nucleic Acids Res. doi:10.1093/nar/gks374
11. J. Xia, N. Psychogios, N. Young, and D.S. Wishart MetaboAnalyst: a web server for metabolomic data analysis and interpretation Nucl. Acids Res. 37 2009 W652 W660 10.1093/nar/gkp356
12. F. Dieterle, A. Ross, Schlotterbeck Gã, and H. Senn Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics Anal. Chem. Am. Chem. Soc. 78 2006 4281 4290 10.1021/ac051632c
13. R. Steuer, K. Morgenthal, W. Weckwerth, and J. Selbig A Gentle Guide to the Analysis of Metabolomic Data Metabolomics. Methods in Molecular Biology 2007 Walker JM. Humana Press Totowa, New Jersey 105 126
14. O. Fiehn, and T. Kind Metabolite profiling in blood plasma. Metabolomics. Weckwerth W. Totawa 2007 Humana Press Totowa, New Jersey 3 17
15. K. Morgenthal, S. Wienkoop, F. Wolschin, and W. Weckwerth Integrative profiling of metabolites and proteins: improving pattern recognition and biomarker selection for systems level approaches Methods Mol. Biol. Clifton NJ. 358 2007 57 75 10.1007/978-1-59745-244-1-4
16. J. Boccard, E. Grata, A. Thiocone, J.-Y. Gauvrit, P. Lantéri, P.-A. Carrupt, and et al. Multivariate data analysis of rapid LC-TOF/MS experiments from Arabidopsis thaliana stressed by wounding Chemom. Intell. Lab. Syst. 86 2007 189 197 10.1016/j.chemolab.2006.06.004
17. H. Wold Estimation of Principal Components and Related Models by Iterative Least Squares 1966 Multivariate analysis New York 391 420
18. S. Wold, M. Sjöström, and L. Eriksson PLS-regression: a basic tool of chemometrics Chemom. Intell. Lab. Syst. 58 2001 109 130 10.1016/S0169-7439(01)00155-1
19. J. Franklin The elements of statistical learning: data mining, inference and prediction 27 2005 Math Intell. Springer-Verlag New York 83 85 10.1007/bf02985802
20. L. Vaclavik, A. Schreiber, O. Lacina, T. Cajka, and J. Hajslova Liquid chromatography-mass spectrometry-based metabolomics for authenticity assessment of fruit juices Metabolomics 8 2011 793 803 10.1007/s11306-011-0371-7
21. R.A. van den Berg, H.C. Hoefsloot, J.A. Westerhuis, A.K. Smilde, and M.J. van der Werf Centering, scaling, and transformations: improving the biological information content of metabolomics data BMC Genom. 7 2006 142 doi:1471-2164-7-142 [pii]10.1186/1471-2164-7-142 [doi]
22. L. Vaclavik, A. Schreiber, O. Lacina, T. Cajka, and J. Hajslova Liquid chromatography-mass spectrometry-based metabolomics for authenticity assessment of fruit juices Metabolomics 8 2012 793 803 10.1007/s11306-011-0371-7
23. B. Worley, and R. Powers Multivariate Analysis in Metabolomics Curr. Metabol. 1 2013 92 107 10.2174/2213235X11301010092
24. J. Godzien, M. Ciborowski, S. Angulo, and C. Barbas From numbers to a biological sense: how the strategy chosen for metabolomics data treatment may affect final results. A practical example based on urine fingerprints obtained by LC-MS Electrophoresis. 34 2013 2812 2826 10.1002/elps.201300053
25. J. Xia, D.I. Broadhurst, M. Wilson, and D.S. Wishart Translational biomarker discovery in clinical metabolomics: an introductory tutorial Metabol. J. Metabol. Soc. 9 2013 280 299 10.1007/s11306-012-0482-9
26. T.A. Lasko, J.G. Bhagwat, K.H. Zou, and L. Ohno-Machado The use of receiver operating characteristic curves in biomedical informatics J. Biomed. Inf. 38 2005 404 415 10.1016/j.jbi.2005.02.008
27. C. Zhu, Q. Liang, P. Hu, Y. Wang, and G. Luo Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy Talanta 85 2011 1711 1720 10.1016/j.talanta.2011.05.036
28. X. Su, X. Han, D.J. Mancuso, D.R. Abendschein, and R.W. Gross Accumulation of long-chain acylcarnitine and 3-hydroxy acylcarnitine molecular species in diabetic myocardium: identification of alterations in mitochondrial fatty acid processing in diabetic myocardium by shotgun lipidomics Biochem. (Mosc.) 44 2005 5234 5245 10.1021/bi047773a
29. Y. Tomiki, S. Suda, M. Tanaka, A. Okuzawa, M. Matsuda, Y. Ishibiki, and et al. Reduced low-density-lipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer. A case control study J. Exp. Clin. Cancer Res. 23 2004 233 240
30. G. Boden, and G.I. Shulman Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction Eur. J. Clin. Investig. 32 Suppl 3 2002 14 23
31. F.F. Hsu, A. Bohrer, M. Wohltmann, S. Ramanadham, Z. Ma, K. Yarasheski, and et al. Electrospray ionization mass spectrometric analyses of changes in tissue phospholipid molecular species during the evolution of hyperlipidemia and hyperglycemia in Zucker diabetic fatty rats Lipids 35 2000 839 854
32. K.C.B. Tan, S.W.M. Shiu, and Y. Wong Plasma phospholipid transfer protein activity and small, dense LDL in type 2 diabetes mellitus Eur. J. Clin. Investig. 33 2003 301 306 10.1046/j.1365-2362.2003.01132.x
33. A.M. Abu El-Asrar, G. Mohammad, M.I. Nawaz, M.M. Siddiquei, D. Kangave, and G. Opdenakker Expression of lysophosphatidic acid, autotaxin and acylglycerol kinase as biomarkers in diabetic retinopathy Acta Diabetol. 50 2013 363 371 10.1007/s00592-012-0422-1
34. J. Aoki, A. Inoue, and S. Okudaira Two pathways for lysophosphatidic acid production Biochim. Biophys. Acta. 1781 2008 513 518 10.1016/j.bbalip.2008.06.005
35. A.L. Bolen, A.P. Naren, S. Yarlagadda, S. Beranova-Giorgianni, L. Chen, D. Norman, and et al. The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation J. Lipid Res. 52 2011 958 970 10.1194/jlr.M013326
36. J. Graessler, D. Schwudke, P.E.H. Schwarz, R. Herzog, A. Shevchenko, and S.R. Bornstein Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients Plos. One 4 2009 e6261 10.1371/journal.pone.0006261
37. E.P. Rhee, S. Cheng, M.G. Larson, G.A. Walford, G.D. Lewis, E. McCabe, and et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans J. Clin. Investig. 121 2011 1402 1411 10.1172/JCI44442
38. X. Zhao, J. Fritsche, J. Wang, J. Chen, K. Rittig, P. Schmitt-Kopplin, and et al. Metabonomic fingerprints of fasting plasma and spot urine reveal human pre-diabetic metabolic traits Metabol. J. Metabol. Soc. 6 2010 362 374 10.1007/s11306-010-0203-1
39. M.N. Barber, S. Risis, C. Yang, P.J. Meikle, M. Staples, M.A. Febbraio, and et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes Plos. One 7 2012 e41456 10.1371/journal.pone.0041456
40. K. Yea, J. Kim, J.H. Yoon, T. Kwon, J.H. Kim, B.D. Lee, and et al. Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes J. Biol. Chem. 284 2009 33833 33840 10.1074/jbc.M109.024869
41. B. García-Fontana, S. Morales-Santana, V. Longobardo, R. Reyes-García, P. Rozas-Moreno, J.A. García-Salcedo, and et al. Relationship between Proinflammatory and Antioxidant Proteins with the Severity of Cardiovascular Disease in Type 2 Diabetes Mellitus Int. J. Mol. Sci. 16 2015 9469 9483 10.3390/ijms16059469
42. B.N. Hammack, K.Y.C. Fung, S.W. Hunsucker, M.W. Duncan, M.P. Burgoon, G.P. Owens, and et al. Proteomic analysis of multiple sclerosis cerebrospinal fluid Mult. Scler. Houndmills Basingstoke Engl. 10 2004 245 260
43. N. Oikonomou, M.-A. Mouratis, A. Tzouvelekis, E. Kaffe, C. Valavanis, G. Vilaras, and et al. Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis Am. J. respir. Cell. Mol. Biol. 47 2012 566 574 10.1165/rcmb.2012-0004OC
44. K. Umemura, N. Yamashita, X. Yu, K. Arima, T. Asada, T. Makifuchi, and et al. utotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients Neurosci. Lett. 400 2006 97 100 10.1016/j.neulet.2006.02.008
45. T. Nakasaki, T. Tanaka, S. Okudaira, M. Hirosawa, E. Umemoto, K. Otani, and et al. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions Am. J. Pathol. 173 2008 1566 1576 10.2353/ajpath.2008.071153
46. J.-M. Wu, Y. Xu, N.J. Skill, H. Sheng, Z. Zhao, M. Yu, and et al. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma Mol. Cancer 9 2010 71 10.1186/1476-4598-9-71
47. H. Kanda, R. Newton, R. Klein, Y. Morita, M.D. Gunn, and S.D. Rosen Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs Nat. Immunol. 9 2008 415 423 10.1038/ni1573
48. C. Chen, L.N. Ochoa, A. Kagan, H. Chai, Z. Liang, P.H. Lin, and et al. Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells Atherosclerosis 222 2012 74 83 10.1016/j.atherosclerosis.2012.02.010
49. J. Boucher, D. Quilliot, J.P. Pradères, M.F. Simon, S. Grès, C. Guigné, and et al. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression Diabetologia 48 2005 569 577 10.1007/s00125-004-1660-8
50. C. Rancoule, R. Dusaulcy, K. Tréguer, S. Grès, C. Guigné, D. Quilliot, and et al. Depot-specific regulation of autotaxin with obesity in human adipose tissue J. Physiol. Biochem. 68 2012 635 644 10.1007/s13105-012-0181-z